Funding Rounds
Cambridge Epigenetix Series D (2021, $88M)
Cambridge EpigenetixPlatform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.
Summary
Stage: Series D
Raised Amount: $88.00M
Raised Date: 2021-01-01